CannLabs, Inc. (CANL)
CannLabs, Inc. operates in the Specialty Business Services industry of the Industrials sector, headquartered in Denver, CO, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $93,317. On trailing twelve-month figures it carries a trailing P/E of 0.09, a net margin of 19.8%. Its beta of 0.36 implies it has historically moved less than the broad market.
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
CannLabs, Inc. is most often compared with the following Industrials names: